Down But Not Out: Health Care Private Equity Deals Reached Nearly $90 Billion in 2022, The Industry's Second-biggest Year on Record

Bain & Company report shows resilience of health care in a downturn, citing biopharma and life sciences, value-based care and AI as areas for investors to watch

Bain & Company’s recently released 12th annual Global Healthcare Private Equity and M&A report reflects the continued resilience of the health care industry, with 2022 seeing near-record levels of health care dealmaking, in terms of both volume and value.